Persons with dispensed medicines; age and sex
| Sex | Ages | Medicine group (ATC) | Periods | Persons with dispensed medicines (number) | Persons with medicines, relative (%) |
|---|---|---|---|---|---|
| Total male and female | Total age | A03C Antispasmodics with psycholeptics | 2022* | 0 | 0.00 |
| Total male and female | Total age | A03D Antispasmodics with analgesics | 2022* | 0 | 0.00 |
| Total male and female | Total age | A07C Electrolytes with carbohydrates | 2022* | 5 | 0.00 |
| Total male and female | Total age | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 1,405 | 0.01 |
| Total male and female | Total age | D07B Corticosteroids with antiseptics | 2022* | 0 | 0.00 |
| Total male and female | Total age | D07C Corticosteroids with antibiotics | 2022* | 0 | 0.00 |
| Total male and female | 0 to 15 years | A03C Antispasmodics with psycholeptics | 2022* | 0 | 0.00 |
| Total male and female | 0 to 15 years | A03D Antispasmodics with analgesics | 2022* | 0 | 0.00 |
| Total male and female | 0 to 15 years | A07C Electrolytes with carbohydrates | 2022* | 0 | 0.00 |
| Total male and female | 0 to 15 years | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 5 | 0.00 |
| Total male and female | 0 to 15 years | D07B Corticosteroids with antiseptics | 2022* | 0 | 0.00 |
| Total male and female | 0 to 15 years | D07C Corticosteroids with antibiotics | 2022* | 0 | 0.00 |
| Total male and female | 15 to 25 years | A03C Antispasmodics with psycholeptics | 2022* | 0 | 0.00 |
| Total male and female | 15 to 25 years | A03D Antispasmodics with analgesics | 2022* | 0 | 0.00 |
| Total male and female | 15 to 25 years | A07C Electrolytes with carbohydrates | 2022* | 0 | 0.00 |
| Total male and female | 15 to 25 years | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 40 | 0.00 |
| Total male and female | 15 to 25 years | D07B Corticosteroids with antiseptics | 2022* | 0 | 0.00 |
| Total male and female | 15 to 25 years | D07C Corticosteroids with antibiotics | 2022* | 0 | 0.00 |
| Total male and female | 25 to 35 years | A03C Antispasmodics with psycholeptics | 2022* | 0 | 0.00 |
| Total male and female | 25 to 35 years | A03D Antispasmodics with analgesics | 2022* | 0 | 0.00 |
| Total male and female | 25 to 35 years | A07C Electrolytes with carbohydrates | 2022* | 0 | 0.00 |
| Total male and female | 25 to 35 years | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 170 | 0.01 |
| Total male and female | 25 to 35 years | D07B Corticosteroids with antiseptics | 2022* | 0 | 0.00 |
| Total male and female | 25 to 35 years | D07C Corticosteroids with antibiotics | 2022* | 0 | 0.00 |
| Total male and female | 35 to 45 years | A03C Antispasmodics with psycholeptics | 2022* | 0 | 0.00 |
| Total male and female | 35 to 45 years | A03D Antispasmodics with analgesics | 2022* | 0 | 0.00 |
| Total male and female | 35 to 45 years | A07C Electrolytes with carbohydrates | 2022* | 0 | 0.00 |
| Total male and female | 35 to 45 years | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 245 | 0.01 |
| Total male and female | 35 to 45 years | D07B Corticosteroids with antiseptics | 2022* | 0 | 0.00 |
| Total male and female | 35 to 45 years | D07C Corticosteroids with antibiotics | 2022* | 0 | 0.00 |
| Total male and female | 45 to 55 years | A03C Antispasmodics with psycholeptics | 2022* | 0 | 0.00 |
| Total male and female | 45 to 55 years | A03D Antispasmodics with analgesics | 2022* | 0 | 0.00 |
| Total male and female | 45 to 55 years | A07C Electrolytes with carbohydrates | 2022* | 0 | 0.00 |
| Total male and female | 45 to 55 years | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 355 | 0.01 |
| Total male and female | 45 to 55 years | D07B Corticosteroids with antiseptics | 2022* | 0 | 0.00 |
| Total male and female | 45 to 55 years | D07C Corticosteroids with antibiotics | 2022* | 0 | 0.00 |
| Total male and female | 55 to 65 years | A03C Antispasmodics with psycholeptics | 2022* | 0 | 0.00 |
| Total male and female | 55 to 65 years | A03D Antispasmodics with analgesics | 2022* | 0 | 0.00 |
| Total male and female | 55 to 65 years | A07C Electrolytes with carbohydrates | 2022* | 0 | 0.00 |
| Total male and female | 55 to 65 years | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 325 | 0.01 |
| Total male and female | 55 to 65 years | D07B Corticosteroids with antiseptics | 2022* | 0 | 0.00 |
| Total male and female | 55 to 65 years | D07C Corticosteroids with antibiotics | 2022* | 0 | 0.00 |
| Total male and female | 65 to 75 years | A03C Antispasmodics with psycholeptics | 2022* | 0 | 0.00 |
| Total male and female | 65 to 75 years | A03D Antispasmodics with analgesics | 2022* | 0 | 0.00 |
| Total male and female | 65 to 75 years | A07C Electrolytes with carbohydrates | 2022* | 0 | 0.00 |
| Total male and female | 65 to 75 years | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 190 | 0.01 |
| Total male and female | 65 to 75 years | D07B Corticosteroids with antiseptics | 2022* | 0 | 0.00 |
| Total male and female | 65 to 75 years | D07C Corticosteroids with antibiotics | 2022* | 0 | 0.00 |
| Total male and female | 75 years or older | A03C Antispasmodics with psycholeptics | 2022* | 0 | 0.00 |
| Total male and female | 75 years or older | A03D Antispasmodics with analgesics | 2022* | 0 | 0.00 |
| Total male and female | 75 years or older | A07C Electrolytes with carbohydrates | 2022* | 0 | 0.00 |
| Total male and female | 75 years or older | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 80 | 0.00 |
| Total male and female | 75 years or older | D07B Corticosteroids with antiseptics | 2022* | 0 | 0.00 |
| Total male and female | 75 years or older | D07C Corticosteroids with antibiotics | 2022* | 0 | 0.00 |
| Total male and female | 0 to 5 years | A03C Antispasmodics with psycholeptics | 2022* | 0 | 0.00 |
| Total male and female | 0 to 5 years | A03D Antispasmodics with analgesics | 2022* | 0 | 0.00 |
| Total male and female | 0 to 5 years | A07C Electrolytes with carbohydrates | 2022* | 0 | 0.00 |
| Total male and female | 0 to 5 years | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 5 | 0.00 |
| Total male and female | 0 to 5 years | D07B Corticosteroids with antiseptics | 2022* | 0 | 0.00 |
| Total male and female | 0 to 5 years | D07C Corticosteroids with antibiotics | 2022* | 0 | 0.00 |
| Total male and female | 5 to 10 years | A03C Antispasmodics with psycholeptics | 2022* | 0 | 0.00 |
| Total male and female | 5 to 10 years | A03D Antispasmodics with analgesics | 2022* | 0 | 0.00 |
| Total male and female | 5 to 10 years | A07C Electrolytes with carbohydrates | 2022* | 0 | 0.00 |
| Total male and female | 5 to 10 years | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 0 | 0.00 |
| Total male and female | 5 to 10 years | D07B Corticosteroids with antiseptics | 2022* | 0 | 0.00 |
| Total male and female | 5 to 10 years | D07C Corticosteroids with antibiotics | 2022* | 0 | 0.00 |
| Total male and female | 10 to 15 years | A03C Antispasmodics with psycholeptics | 2022* | 0 | 0.00 |
| Total male and female | 10 to 15 years | A03D Antispasmodics with analgesics | 2022* | 0 | 0.00 |
| Total male and female | 10 to 15 years | A07C Electrolytes with carbohydrates | 2022* | 0 | 0.00 |
| Total male and female | 10 to 15 years | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 0 | 0.00 |
| Total male and female | 10 to 15 years | D07B Corticosteroids with antiseptics | 2022* | 0 | 0.00 |
| Total male and female | 10 to 15 years | D07C Corticosteroids with antibiotics | 2022* | 0 | 0.00 |
| Total male and female | 15 to 20 years | A03C Antispasmodics with psycholeptics | 2022* | 0 | 0.00 |
| Total male and female | 15 to 20 years | A03D Antispasmodics with analgesics | 2022* | 0 | 0.00 |
| Total male and female | 15 to 20 years | A07C Electrolytes with carbohydrates | 2022* | 0 | 0.00 |
| Total male and female | 15 to 20 years | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 5 | 0.00 |
| Total male and female | 15 to 20 years | D07B Corticosteroids with antiseptics | 2022* | 0 | 0.00 |
| Total male and female | 15 to 20 years | D07C Corticosteroids with antibiotics | 2022* | 0 | 0.00 |
| Total male and female | 20 to 25 years | A03C Antispasmodics with psycholeptics | 2022* | 0 | 0.00 |
| Total male and female | 20 to 25 years | A03D Antispasmodics with analgesics | 2022* | 0 | 0.00 |
| Total male and female | 20 to 25 years | A07C Electrolytes with carbohydrates | 2022* | 0 | 0.00 |
| Total male and female | 20 to 25 years | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 30 | 0.00 |
| Total male and female | 20 to 25 years | D07B Corticosteroids with antiseptics | 2022* | 0 | 0.00 |
| Total male and female | 20 to 25 years | D07C Corticosteroids with antibiotics | 2022* | 0 | 0.00 |
| Total male and female | 25 to 30 years | A03C Antispasmodics with psycholeptics | 2022* | 0 | 0.00 |
| Total male and female | 25 to 30 years | A03D Antispasmodics with analgesics | 2022* | 0 | 0.00 |
| Total male and female | 25 to 30 years | A07C Electrolytes with carbohydrates | 2022* | 0 | 0.00 |
| Total male and female | 25 to 30 years | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 70 | 0.01 |
| Total male and female | 25 to 30 years | D07B Corticosteroids with antiseptics | 2022* | 0 | 0.00 |
| Total male and female | 25 to 30 years | D07C Corticosteroids with antibiotics | 2022* | 0 | 0.00 |
| Total male and female | 30 to 35 years | A03C Antispasmodics with psycholeptics | 2022* | 0 | 0.00 |
| Total male and female | 30 to 35 years | A03D Antispasmodics with analgesics | 2022* | 0 | 0.00 |
| Total male and female | 30 to 35 years | A07C Electrolytes with carbohydrates | 2022* | 0 | 0.00 |
| Total male and female | 30 to 35 years | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 105 | 0.01 |
| Total male and female | 30 to 35 years | D07B Corticosteroids with antiseptics | 2022* | 0 | 0.00 |
| Total male and female | 30 to 35 years | D07C Corticosteroids with antibiotics | 2022* | 0 | 0.00 |
| Total male and female | 35 to 40 years | A03C Antispasmodics with psycholeptics | 2022* | 0 | 0.00 |
| Total male and female | 35 to 40 years | A03D Antispasmodics with analgesics | 2022* | 0 | 0.00 |
| Total male and female | 35 to 40 years | A07C Electrolytes with carbohydrates | 2022* | 0 | 0.00 |
| Total male and female | 35 to 40 years | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 115 | 0.01 |
| Source: CBS. | |||||
Dataset is not available.
This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. Also, the number of dispensed defined daily doses (DDDs) are presented. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Personal Records Database (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.
Data are broken down by medicine group, age and sex.
Data available from: 2006
Status of the figures:
Figures for 2022 are provisional.
Changes as of December 20, 2023:
- Provisional figures for 2022 have been added, provisional figures of 2020 and 2021 have been made definite.
- Textual change: the description of drug group Y (Not filled in) has been replaced by Z (Not applicable). However, the underlying resources have remained the same. This category is assigned to products that do not have an ATC code according to the WHO ATC classification system.
When will new figures be published?
New figures will be published in the last quarter of 2024.
Description topics
- Persons with dispensed medicines
- Number of persons registered in the Basic Registration of Persons (BRP) in the year concerned to whom medicines are dispensed in that year that are reimbursed under the statutory basic medical insurance.
- Persons with medicines, relative
- Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.